Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme

被引:61
作者
Escrevente, Cristina [1 ]
Morais, Vanessa A. [1 ]
Keller, Sascha [2 ]
Soares, Claudio M. [1 ]
Altevogt, Peter [2 ]
Costa, Julia [1 ]
机构
[1] Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal
[2] German Canc Res Ctr, Tumor Immunol Programme, D-6900 Heidelberg, Germany
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2008年 / 1780卷 / 06期
关键词
ADAM10; N-linked glycosylation; L1; shedding; ovarian carcinoma; exosomes;
D O I
10.1016/j.bbagen.2008.03.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A disintegrin and metalloprotease 10 (ADAM10) is a type I transmembrane glycoprotein with four potential N-glycosylation sites (N267, N278, N439 and N551), that cleaves several plasma membrane proteins. In this work, ADAM10 was found to contain high-mannose and complex-type glycans. Individual N-glycosylation site mutants S269A, T280A, S441A, T553A were constructed, and results indicated that all sites were occupied. T280A was found to accumulate in the endoplasmic reticulum as the non-processed precursor of the enzyme. Furthermore, it exhibited only residual levels of metalloprotease activity in vivo towards the L1 cell adhesion molecule, as well as in vitro, using a ProTNF-alpha peptide as substrate. S441A showed increased ADAM10 susceptibility to proteolysis. Mutation of N267, N439 and N551 did not completely abolish enzyme activity, however, reduced levels were found. ADAM10 is sorted into secretory vesicles, the exosomes. Here, a fraction of ADAM10 from exosomes was found to contain more processed Winked glycans than the cellular enzyme. In conclusion, N-glycosylation is crucial for ADAM10 processing and resistance to proteolysis, and results suggest that it is required for full-enzyme activity. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:905 / 913
页数:9
相关论文
共 53 条
  • [1] Regulation of the α-secretase ADAM10 by its prodomain and proprotein convertases
    Anders, A
    Gilbert, S
    Garten, W
    Postina, R
    Fahrenholz, F
    [J]. FASEB JOURNAL, 2001, 15 (08) : 1837 - +
  • [2] ARRIBAS J, 2005, ADAM, V17
  • [3] Characterization of N-glycosylation consensus sequences in the Kv3.1 channel
    Brooks, Natasha L.
    Corey, Melissa J.
    Schwalbe, Ruth A.
    [J]. FEBS JOURNAL, 2006, 273 (14) : 3287 - 3300
  • [4] Exosomal-like vesicles are present in human blood plasma
    Caby, MP
    Lankar, D
    Vincendeau-Scherrer, C
    Raposo, G
    Bonnerot, C
    [J]. INTERNATIONAL IMMUNOLOGY, 2005, 17 (07) : 879 - 887
  • [5] The role of N-glycosylation in the stability, trafficking and GABA-uptake of GABA-transporter 1 -: Terminal N-glycans facilitate efficient GABA-uptake activity of the GABA transporter
    Cai, GQ
    Salonikidis, PS
    Fei, J
    Schwarz, W
    Schülein, R
    Reutter, W
    Fan, H
    [J]. FEBS JOURNAL, 2005, 272 (07) : 1625 - 1638
  • [6] Localization of ADAM10 and notch receptors in bone
    Dallas, DJ
    Genever, PG
    Patton, AJ
    Millichip, MI
    McKie, N
    Skerry, TM
    [J]. BONE, 1999, 25 (01) : 9 - 15
  • [7] DeLano W.L, 2002, The Pymol Molecular Graphics System Version 1.0
  • [8] Glycans in cancer and inflammation. Potential for therapeutics and diagnostics
    Dube, DH
    Bertozzi, CR
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (06) : 477 - 488
  • [9] L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas
    Fogel, M
    Gutwein, P
    Mechtersheimer, S
    Riedle, S
    Stoeck, A
    Smirnov, A
    Edler, L
    Ben-Arie, A
    Huszar, M
    Altevogt, P
    [J]. LANCET, 2003, 362 (9387) : 869 - 875
  • [10] L 1 adhesion molecule (CD 171) in development and progression of human malignant melanoma
    Fogel, M
    Mechtersheimer, S
    Huszar, M
    Smirnov, A
    Abu-Dahi, A
    Tilgen, W
    Reichrath, J
    Georg, T
    Altevogt, P
    Gutwein, P
    [J]. CANCER LETTERS, 2003, 189 (02) : 237 - 247